Status:
COMPLETED
High-sensitivity Troponin in Cardiac Surgery
Lead Sponsor:
Onze Lieve Vrouw Hospital
Collaborating Sponsors:
Roche Farma, S.A
Conditions:
Heart; Dysfunction Postoperative, Cardiac Surgery
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Among patients undergoing heart surgery, a measurable degree of heart muscle tissue injury is expected. The level of injury can be shown by measuring the blood levels of specific molecules called card...
Detailed Description
This is a prospective interventional mono centre study. High-sensitivity troponin and CK-MB will be measured at different point of times in all adult patients undergoing cardiac surgery. Experiments ...
Eligibility Criteria
Inclusion
- Each participant must be older than 18 years
- Undergoing cardiac surgery
- Each participant must have the mental capacity to decide whether he takes part in the trial or not.
- Each participant must voluntarily give his written informed consent.
Exclusion
- Patients with severe or end-stage renal insufficiency.
- Insertion of assist devices.
- Surgery on urgent basis, that is, the same day after their coronary angiogram.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01913873
Start Date
January 1 2014
End Date
March 1 2015
Last Update
March 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Unit, OLV Hospital Aalst, Belgium
Aalst, East-Flanders, Belgium, 9300